Unknown

Dataset Information

0

Insulin degludec: a significant advancement in ultralong-acting Basal insulin.


ABSTRACT: This editorial discusses a novel basal insulin analog, insulin degludec. It describes the limitations of existing basal insulins, and builds the case for a better analog. The editorial discusses the evidence to support the efficacy, safety, tolerability, and flexibility of degludec, and assesses its utility as part of a person-centered approach to diabetes management.

SUBMITTER: Kalra S 

PROVIDER: S-EPMC3889334 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3402007 | biostudies-other
| S-EPMC4452210 | biostudies-literature
| S-EPMC6531575 | biostudies-literature
| S-EPMC8470485 | biostudies-literature
| S-EPMC4931208 | biostudies-literature
| S-EPMC7547940 | biostudies-literature
| S-EPMC3041203 | biostudies-literature
| S-EPMC5009132 | biostudies-literature
| S-EPMC4946153 | biostudies-literature
| S-EPMC6825933 | biostudies-literature